Healthcare provider profile · identity verified

Srirama Josyula, MD

Internal Medicine · SEATTLE, WA · NPI 1053817510

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	431	75
Metoprolol Succinate	Metoprolol Succinate	295	47
Omeprazole	Omeprazole	293	53
Amlodipine Besylate	Amlodipine Besylate	256	49
Gabapentin	Gabapentin	255	51
Losartan Potassium	Losartan Potassium	222	40
Famotidine	Famotidine	212	32
Lisinopril	Lisinopril	208	35
Metformin Hcl	Metformin Hcl	171	34
Tamsulosin Hcl	Tamsulosin Hcl	164	29
Levothyroxine Sodium	Levothyroxine Sodium	150	24
Albuterol Sulfate Hfa	Albuterol Sulfate	142	40
Jardiance	Empagliflozin	136	22
Fluticasone Propionate	Fluticasone Propionate	127	29
Simvastatin	Simvastatin	123	23
Mirtazapine	Mirtazapine	100	17
Diclofenac Sodium	Diclofenac Sodium	96	30
Triamcinolone Acetonide	Triamcinolone Acetonide	92	24
Trazodone Hcl	Trazodone Hcl	90	16
Rosuvastatin Calcium	Rosuvastatin Calcium	83	12
Ketoconazole	Ketoconazole	81	13
Sertraline Hcl	Sertraline Hcl	81	12
Ventolin Hfa	Albuterol Sulfate	79	15
Allopurinol	Allopurinol	78	suppressed
Spironolactone	Spironolactone	77	14
Metformin Hcl Er	Metformin Hcl	67	13
Pantoprazole Sodium	Pantoprazole Sodium	65	12
Pregabalin	Pregabalin	64	12
Ammonium Lactate	Ammonium Lactate	60	14
Furosemide	Furosemide	59	12
Trulicity	Dulaglutide	59	suppressed
Alendronate Sodium	Alendronate Sodium	54	suppressed
Symbicort	Budesonide/Formoterol Fumarate	49	suppressed
Eliquis	Apixaban	47	suppressed
Hydrocortisone	Hydrocortisone	46	13
Meloxicam	Meloxicam	46	12
Potassium Chloride	Potassium Chloride	46	suppressed
Clotrimazole	Clotrimazole	44	21
Myrbetriq	Mirabegron	43	suppressed
Duloxetine Hcl	Duloxetine Hcl	42	suppressed
Montelukast Sodium	Montelukast Sodium	42	suppressed
Ozempic	Semaglutide	42	suppressed
Chlorthalidone	Chlorthalidone	39	suppressed
Topiramate	Topiramate	39	suppressed
Xarelto	Rivaroxaban	39	suppressed
Citalopram Hbr	Citalopram Hydrobromide	38	suppressed
Finasteride	Finasteride	35	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	35	suppressed
Tizanidine Hcl	Tizanidine Hcl	35	13
Farxiga	Dapagliflozin Propanediol	31	suppressed
Lidocaine	Lidocaine	31	suppressed
Clopidogrel	Clopidogrel Bisulfate	30	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	29	suppressed
Glipizide	Glipizide	27	suppressed
Baclofen	Baclofen	26	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	26	suppressed
Clobetasol Propionate	Clobetasol Propionate	26	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Nitroglycerin	Nitroglycerin	26	suppressed
Prazosin Hcl	Prazosin Hcl	26	suppressed
Risperidone	Risperidone	26	suppressed
Valacyclovir	Valacyclovir Hcl	25	suppressed
Aripiprazole	Aripiprazole	24	suppressed
Azithromycin	Azithromycin	24	19
Calcipotriene	Calcipotriene	24	suppressed
Clonazepam	Clonazepam	24	suppressed
Naproxen	Naproxen	24	suppressed
Eplerenone	Eplerenone	23	suppressed
Metronidazole	Metronidazole	23	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	22	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	21	suppressed
Humulin N	Insulin Nph Human Isophane	21	suppressed
Carvedilol	Carvedilol	20	suppressed
Selenium Sulfide	Selenium Sulfide	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Tradjenta	Linagliptin	19	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Proctozone-Hc	Hydrocortisone	18	suppressed
Restasis	Cyclosporine	18	suppressed
Fluocinonide	Fluocinonide	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Haloperidol	Haloperidol	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Spiriva Handihaler	Tiotropium Bromide	17	suppressed
Arnuity Ellipta	Fluticasone Furoate	16	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	14	suppressed
Estradiol	Estradiol	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Fluocinolone Acetonide	Fluocinolone Acetonide	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Trueplus Pen Needle	Pen Needle, Diabetic	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Dulera	Mometasone/Formoterol	12	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Lamictal	Lamotrigine	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Potassium Citrate Er	Potassium Citrate	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed
Torsemide	Torsemide	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Trueplus Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error